home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
TRACON Pharmaceuticals Announces Initiation of TRC102 Phase 2 Clinical Trial in Glioblastoma
TRACON Pharmaceuticals Announces Initiation of TRC102 Phase 2 Clinical Trial in Glioblastoma
Post navigation
Previous Post
Previous
Jounce Therapeutics Appoints Perry Karsen to its Board of Directors
Next Post
Next
Blueprint Medicines Reports Fourth Quarter and Full Year 2015 Financial Results